|
Therapeutic
Area
|
Product
/ Brand Name
|
Indication
|
| |
|
|
| Virology |
Cymevene®
(ganciclovir)
|
For the prevention & treatment of CMV disease in immuno
- compromised individuals & for the prevention of CMV
disease in transplant recipients.
|
|
Invirase®
(saquinavir) |
For the treatment of advanced HIV infection
|
|
Roferon-A®
(interferon
alfa-2a) |
For the treatment of multiple myeloma, Kapozi's sarcoma
in AIDS patients with malignant neoplasia, hairy cell leukemia,
chronic myelogenous leukemia, chronic active Hepatitis B
& C.
|
|
Fortovase®
(saquinavir
soft gel caps) |
For the treatment of advanced HIV infection
|
|
Pegasys
®
(Peginterferon
alfa-2a 40 KD)
|
Treatment of Multiple Myeloma , Kapozy's
Sarcoma in AIDS patients with Malignant Neoplasia , Hairy
Cell Leukemia, Chronic Myelogenous Leukemia, Chronic Active
Hepatitis B & C
|
| |
Valcyte®
(valganciclovir) |
Treatment of cytomegalovirus (CMV) retinitis in AIDS patients
and prevention of CMV disease in solid organ transplant
patients at high risk.
|
|
Currently distributed in
India by:-
Taksal Pharma Pvt. Ltd.
9-10/3, Asaf Ali Road
Laxman House, Ground Floor
New Delhi 110 002
Tel. +91 11 23240071-74
+91 11 30128001-4
Fax +91 11 23240075
|
| |
